*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Immunex/NNP Corp./NNP ]
and/CC 
[ Receptech/NNP Corp./NNP ]
said/VBD 
[ they/PRP ]
filed/VBD 
[ a/DT joint/JJ registration/NN statement/NN ]
with/IN 
[ the/DT Securities/NNP ]
and/CC 
[ Exchange/NNP Commission/NNP ]
for/IN 
[ a/DT proposed/VBN initial/JJ public/JJ offering/NN ]
of/IN 
[ 2.5/CD million/CD units/NNS ]
for/IN 
[ $/$ 30/CD million/CD ]
,/, or/CC 
[ $/$ 12/CD ]

[ a/DT unit/NN ]
./. 

======================================

Under/IN 
[ the/DT offering/NN ]
,/, 
[ each/DT unit/NN ]
will/MD hold/VB 
[ one/CD share/NN ]
of/IN 
[ callable/JJ common/JJ stock/NN ]
of/IN 
[ Receptech/NNP ]
,/, 
[ a/DT shell/NN ]
formed/VBN by/IN 
[ Immunex/NNP executives/NNS ]
to/TO conduct/VB 
[ research/NN ]
on/IN 
[ Immunex/NNP products/NNS ]
,/, and/CC 
[ a/DT warrant/NN ]
to/TO buy/VB 
[ one/CD Immunex/NNP common/JJ stock/NN ]
./. 

[ The/DT shares/NNS ]
and/CC 
[ warrants/NNS ]
will/MD trade/VB as/IN 
[ one/CD unit/NN ]
through/IN 
[ June/NNP 30/CD ]
,/, 
[ 1992/CD ]
,/, at/IN 
[ which/WDT point/NN ]

[ they/PRP ]
will/MD trade/VB separately/RB ./. 

======================================

[ Immunex/NNP ]
,/, 
[ a/DT biotechnology/NN concern/NN ]
,/, said/VBD 
[ the/DT agreement/NN ]
also/RB allows/VBZ 
[ it/PRP ]
to/TO buy/VB 
[ all/DT Receptech/NNP shares/NNS ]
issued/VBN under/IN 
[ the/DT offering/NN ]
before/IN 
[ June/NNP 30/CD ]
,/, 
[ 1992/CD ]
./. 

======================================

[ A/DT company/NN spokesman/NN ]
said/VBD 
[ such/PDT a/DT transaction/NN ]
would/MD depend/VB on/IN 
[ the/DT merit/NN ]
of/IN 
[ the/DT research/NN ]
conducted/VBN by/IN 
[ Receptech/NNP ]
,/, formed/VBN in/IN 
[ August/NNP ]
to/TO develop/VB 
[ cytokine/NN|JJ receptor/NN products/NNS ]
for/IN 
[ the/DT treatment/NN ]
of/IN 
[ autoimmune/JJ ]
and/CC 
[ inflammatory/JJ diseases/NNS ]
and/CC 
[ conditions/NNS ]
,/, including/VBG 
[ rheumatoid/JJ arthritis/NN ]
,/, 
[ emphysema/NN ]
and/CC 
[ septic/JJ shock/NN ]
./. 

======================================

[ Immunex/NNP ]
and/CC 
[ Receptech/NNP ]
said/VBD 
[ they/PRP ]
have/VBP given/VBN 
[ underwriters/NNS ]

[ the/DT option/NN ]
to/TO buy/VB up/IN to/TO 
[ 375,000/CD additional/JJ units/NNS ]
to/TO cover/VB 
[ over-allotments/NNS ]
./. 

[ Prudential-Bache/NNP Capital/NNP Funding/NNP ]
,/, 
[ New/NNP York/NNP ]
,/, and/CC 
[ Hambrecht/NNP ]
&/CC 
[ Quist/NNP Inc./NNP ]
,/, 
[ San/NNP Francisco/NNP ]
,/, are/VBP managing/NN 
[ underwriters/NNS ]
./. 

======================================

[ The/DT joint/JJ filing/NN ]
follows/VBZ 
[ a/DT series/NN ]
of/IN 
[ Immunex/NNP announcements/NNS last/JJ week/NN ]
under/IN 
[ which/WDT ]

[ the/DT company/NN ]
will/MD re-acquire/VB 
[ the/DT right/NN ]
to/TO 
[ manufacture/VB ]
and/CC 
[ market/VB promising/JJ biological/JJ agents/NNS ]
for/IN 
[ the/DT treatment/NN ]
of/IN 
[ cancer/NN ]
and/CC 
[ immune/JJ dysfunction/NN ]
./. 

======================================

[ Immunex/NNP ]
,/, 
[ which/WDT ]
in/IN 
[ the/DT early/JJ 1980s/NNS ]
licensed/VBD away/RP 
[ the/DT right/NN ]
to/TO make/VB and/CC sell/VB 
[ products/NNS ]

[ it/PRP ]
had/VBD developed/VBN ,/, now/RB has/VBZ shifted/VBN 
[ gears/NNS ]
and/CC is/VBZ reclaiming/VBG 
[ rights/NNS ]
to/TO 
[ such/JJ products/NNS ]
in/IN 
[ an/DT effort/NN ]
to/TO become/VB 
[ a/DT ]
fully/RB integrated/JJ 
[ biopharmaceutical/JJ company/NN ]
./. 
